Back
75· Active
Health & Science18h 42m ago
The FDA has granted marketing authorization for the first non-prescription continuous glucose monitor (CGM) intended for adults who do not use insulin.
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA)
What
The FDA has granted marketing authorization for the first non-prescription continuous glucose monitor (CGM) intended for adults who do not use insulin.
When
Mon, 08 Jun 2026 15:20:06 GMT · 18h 42m ago
Where
Silver Spring, Maryland, USA · 39.034°N, 76.992°W
Why
This regulatory shift aims to provide broader access to metabolic health data for people with Type 2 diabetes who manage their condition with oral medications or those interested in monitoring glucose for wellness.
The Frontline Impact
How this affects you
This expands the healthcare technology market significantly, allowing millions of consumers to purchase blood sugar monitoring sensors without a doctor's visit, potentially improving preventative care and lifestyle management.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.